117 related articles for article (PubMed ID: 19632756)
1. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
Karina E; Tomasz P; Bilar M; Agnieszka O; Ewa B; Elzbieta RW
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
[TBL] [Abstract][Full Text] [Related]
2. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
Tao H; Wang XM; Ji XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
[TBL] [Abstract][Full Text] [Related]
3. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
Cotter AM; Martin CM; O'leary JJ; Daly SF
Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
[TBL] [Abstract][Full Text] [Related]
4. The analysis of the correlation between extracellular fetal DNA concentration in maternal circulation and severity of preeclampsia.
Engel K; Płonka T; Bilar M; Czajkowska E; Orzińska E; Brojer E; Ronin-Walknowska E
Ann Acad Med Stetin; 2007; 53(3):20-5. PubMed ID: 18595481
[TBL] [Abstract][Full Text] [Related]
5. Low plasma levels of oxidized low density lipoprotein in preeclampsia.
Raijmakers MT; van Tits BJ; Hak-Lemmers HL; Roes EM; Steegers EA; Peters WH
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1173-7. PubMed ID: 15548151
[TBL] [Abstract][Full Text] [Related]
6. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia.
Byrne BM; Crowley A; Taulo F; Anthony J; O'Leary JJ; O'Herlihy C
Hypertens Pregnancy; 2003; 22(2):157-64. PubMed ID: 12909000
[TBL] [Abstract][Full Text] [Related]
7. Fetal DNA in maternal plasma as a screening variable for preeclampsia. A preliminary nonparametric analysis of detection rate in low-risk nonsymptomatic patients.
Farina A; Sekizawa A; Sugito Y; Iwasaki M; Jimbo M; Saito H; Okai T
Prenat Diagn; 2004 Feb; 24(2):83-6. PubMed ID: 14974111
[TBL] [Abstract][Full Text] [Related]
8. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
11. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction.
Alberry MS; Maddocks DG; Hadi MA; Metawi H; Hunt LP; Abdel-Fattah SA; Avent ND; Soothill PW
Am J Obstet Gynecol; 2009 Jan; 200(1):98.e1-6. PubMed ID: 19121662
[TBL] [Abstract][Full Text] [Related]
12. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia.
Zhong XY; Laivuori H; Livingston JC; Ylikorkala O; Sibai BM; Holzgreve W; Hahn S
Am J Obstet Gynecol; 2001 Feb; 184(3):414-9. PubMed ID: 11228496
[TBL] [Abstract][Full Text] [Related]
13. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study.
Molvarec A; Prohászka Z; Nagy B; Szalay J; Füst G; Karádi I; Rigó J
J Hum Hypertens; 2006 Oct; 20(10):780-6. PubMed ID: 16761027
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of severe preeclampsia with maternal and fetal mutant alleles for tumor necrosis factor alpha and lymphotoxin alpha genes and plasma tumor necrosis factor alpha levels.
Livingston JC; Park V; Barton JR; Elfering S; Haddad B; Mabie WC; Quasney M; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1273-7. PubMed ID: 11349201
[TBL] [Abstract][Full Text] [Related]
15. Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: case-control study.
Ebrashy A; Azmy O; Ibrahim M; Waly M; Edris A
Croat Med J; 2005 Oct; 46(5):821-5. PubMed ID: 16158478
[TBL] [Abstract][Full Text] [Related]
16. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.
Levine RJ; Qian C; Leshane ES; Yu KF; England LJ; Schisterman EF; Wataganara T; Romero R; Bianchi DW
Am J Obstet Gynecol; 2004 Mar; 190(3):707-13. PubMed ID: 15042003
[TBL] [Abstract][Full Text] [Related]
17. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
18. First-trimester maternal plasma cell-free fetal DNA and preeclampsia.
Sifakis S; Zaravinos A; Maiz N; Spandidos DA; Nicolaides KH
Am J Obstet Gynecol; 2009 Nov; 201(5):472.e1-7. PubMed ID: 19631923
[TBL] [Abstract][Full Text] [Related]
19. Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21.
Spencer K; de Kok JB; Swinkels DW
Prenat Diagn; 2003 Jul; 23(7):580-3. PubMed ID: 12868088
[TBL] [Abstract][Full Text] [Related]
20. [Serum homocysteine levels in pregnant women with preeclampsia].
Stoĭkova V; Ivanov S; Mazneĭkova V; Tsoncheva A
Akush Ginekol (Sofiia); 2005; 44(6):16-9. PubMed ID: 18982827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
